Clinical Trials · NCT01250145

A Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teriparatide Administered Transdermally in Healthy Postmenopausal Women

Name: A Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teriparatide Administered Transdermally in Healthy Postmenopausal Women
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 1Teriparatide

Phase: Phase 1
Recruitment status: Completed
Sponsor: Eli Lilly and Company
Enrollment: 251
Start date: Nov 2010
Locations: 5 sites, 3 countries
Primary endpoint: Part A - Cumulative Skin Irritation by Draize Score

View Teriparatide compound reference